The Significance of HER-2/neu Receptor Positivity and Immunophenotype in Ductal Carcinoma In-Situ with Early Invasive Disease

INTRODUCTION: Biologic markers that predict development of invasive breast cancer (IBC) in patients diagnosed with ductal carcinoma in-situ (DCIS) are needed to improve personalized therapy. In this study, we examined the incidence of early IBC in DCIS subgroups defined by immunophenotype. METHODS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Harada, Shuko, Mick, Rosemarie, Roses, Robert E., Graves, Holley, Niu, Huilin, Sharma, Anupama, Schueller, Jeanne E., Nisenbaum, Harvey, Czerniecki, Brian J., Zhang, Paul J
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3168675/
https://ncbi.nlm.nih.gov/pubmed/21557226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.21973
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky